$LIFE aTYR PHARMA INC Insider Trading Week 19/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in aTYR PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in aTYR PHARMA INC in week 19/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 1,536,787 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 2,127,660 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | C | 0.00 | 893,655 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Buy | C | 0.00 | 1,758,158 | 0 | 1,758,158 | 0 to 1.8 M |
May 14 2015 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Buy | C | 0.00 | 92,306 | 0 | 104,878 | 12.6 K to 104.9 K (+734.22 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Option Exercise | C | 0.00 | 21,122 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Option Exercise | C | 0.00 | 170,218 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | CEO and Executive C ... | Buy | C | 0.00 | 24,055 | 0 | 245,971 | 221.9 K to 246 K (+10.84 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 8,623 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 5,906 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 16,806 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 862,318 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 14,706 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 10,074 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,661 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 1,470,577 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 42,087 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,831 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 82,029 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,208,756 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 41,686 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 28,556 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 81,248 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,168,683 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 34,737 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 23,796 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 67,704 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 3,473,763 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 890 | 0 | 17,638 | 16.7 K to 17.6 K (+5.31 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 610 | 0 | 12,082 | 11.5 K to 12.1 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,736 | 0 | 34,378 | 32.6 K to 34.4 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 89,069 | 0 | 1,763,894 | 1.7 M to 1.8 M (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 16,748 | 0 | 16,748 | 0 to 16.7 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 11,472 | 0 | 11,472 | 0 to 11.5 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 32,642 | 0 | 32,642 | 0 to 32.6 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,674,825 | 0 | 1,674,825 | 0 to 1.7 M |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 1,536,787 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 2,127,660 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Option Exercise | C | 0.00 | 2,400,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | CHP II LP | 10% Owner | Buy | C | 0.00 | 1,758,158 | 0 | 1,758,158 | 0 to 1.8 M |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Option Exercise | C | 0.00 | 14,968,722 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Buy | P | 14.00 | 320,000 | 4,480,000 | 1,866,126 | 1.5 M to 1.9 M (+20.70 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | AKKARAJU SRINIVAS | Director | Buy | C | 0.00 | 1,546,126 | 0 | 1,546,126 | 0 to 1.5 M |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 893,655 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,126,866 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,361,703 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,320,173 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,600,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 92,306 | 0 | 1,778,064 | 1.7 M to 1.8 M (+5.48 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 1,685,758 | 0 | 1,685,758 | 0 to 1.7 M |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 446,827 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 15,031 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 558,508 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,440,058 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 1,200,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | C | 0.00 | 248,024 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 46,152 | 0 | 646,167 | 600 K to 646.2 K (+7.69 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 470,020 | 0 | 600,015 | 130 K to 600 K (+361.57 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | C | 0.00 | 31,181 | 0 | 31,181 | 0 to 31.2 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 14,968,722 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 14.00 | 320,000 | 4,480,000 | 1,866,126 | 1.5 M to 1.9 M (+20.70 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 1,546,126 | 0 | 1,546,126 | 0 to 1.5 M |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 8,623 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 5,906 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 16,806 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 862,318 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 14,706 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 10,074 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 28,661 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 1,470,577 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 42,087 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 28,831 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 82,029 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 4,208,756 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 41,686 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 28,556 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 81,248 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 4,168,683 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 34,737 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 23,796 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 67,704 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | C | 0.00 | 3,473,763 | 0 | 0 | |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 890 | 0 | 17,638 | 16.7 K to 17.6 K (+5.31 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 610 | 0 | 12,082 | 11.5 K to 12.1 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 1,736 | 0 | 34,378 | 32.6 K to 34.4 K (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 89,069 | 0 | 1,763,894 | 1.7 M to 1.8 M (+5.32 %) |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 16,748 | 0 | 16,748 | 0 to 16.7 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 11,472 | 0 | 11,472 | 0 to 11.5 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 32,642 | 0 | 32,642 | 0 to 32.6 K |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | C | 0.00 | 1,674,825 | 0 | 1,674,825 | 0 to 1.7 M |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 2,234,137 | 0 | 0 | |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 2,234,137 | 0 | 0 | |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Buy | P | 14.00 | 25,000 | 350,000 | 255,764 | 230.8 K to 255.8 K (+10.83 %) |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Buy | P | 14.00 | 25,000 | 350,000 | 255,764 | 230.8 K to 255.8 K (+10.83 %) |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Buy | C | 0.00 | 230,764 | 0 | 230,764 | 0 to 230.8 K |
May 13 2015 | LIFE | aTYR PHARMA INC | Flynn James E | 10% Owner | Buy | C | 0.00 | 230,764 | 0 | 230,764 | 0 to 230.8 K |
May 12 2015 | LIFE | aTYR PHARMA INC | DP VIII Associates, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,581 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | DP VIII Associates, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,182 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | DP VIII Associates, L.P. | 10% Owner | Option Exercise | C | 0.00 | 90,110 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | DP VIII Associates, L.P. | 10% Owner | Buy | C | 0.00 | 13,414 | 0 | 13,414 | 0 to 13.4 K |
May 12 2015 | LIFE | aTYR PHARMA INC | Domain Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 887,073 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | Domain Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,506,901 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | Domain Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 12,143,933 | 0 | 0 | |
May 12 2015 | LIFE | aTYR PHARMA INC | Domain Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 1,807,820 | 0 | 1,807,820 | 0 to 1.8 M |